At this point we have all heard how artificial intelligence (AI) will change the world, and many of us have
Continue Reading USPTO Report Shows Tremendous Growth in Patent Filings on Artificial Intelligence
Atea Pharmaceuticals Collaborates with Roche on Oral COVID-19 Therapeutic
On October 22, 2020, Boston-based Atea Pharmaceuticals, Inc. (“Atea”) announced an agreement with Roche for the exclusive rights to research,
Continue Reading Atea Pharmaceuticals Collaborates with Roche on Oral COVID-19 Therapeutic
Ryder Launches $50M Venture Fund for Supply Chain Startups
This week, Ryder System, Inc. (NYSE: R), announced a new corporate venture capital fund called RyderVentures.
The fund seeks to
Continue Reading Ryder Launches $50M Venture Fund for Supply Chain Startups
Key Considerations Regarding Early Disclosures and Patent Protection
Founders routinely need to disclose their groundbreaking technologies to third party investors, suitors, collaborators, peers, consultants and others in order
Continue Reading Key Considerations Regarding Early Disclosures and Patent Protection
Eli Lilly to Buy Disarm Therapeutics for $135M Plus Potentially $1B+
Pharmaceutical giant Eli Lilly and Company will purchase four-year-old Disarm Therapeutics, a Cambridge-based biotechnology company, for $135 million up
Continue Reading Eli Lilly to Buy Disarm Therapeutics for $135M Plus Potentially $1B+
University of Cambridge Develops Virtual Reality Software to Help Explore Cells
Researchers at the University of Cambridge have developed software that produces super-resolution virtual, 3D images of cells contained in actual
Continue Reading University of Cambridge Develops Virtual Reality Software to Help Explore Cells
Moderna Reportedly Won’t Enforce its COVID-19 Vaccine Patents
Boston-based Moderna has announced that it will not enforce its patent rights related to its experimental vaccine for COVID-19, because
Continue Reading Moderna Reportedly Won’t Enforce its COVID-19 Vaccine Patents
Keeping Privacy in Mind in the Early Stages of Your Company
With the EU’s 2018 General Data Protection Regulation (GDPR), the California Consumer Privacy Act (CCPA), which became effective January 2020,
Continue Reading Keeping Privacy in Mind in the Early Stages of Your Company
Scribe Enters CRISPR-Based Collaboration with Biogen
On October 7, 2020, Scribe Therapeutics announced a collaboration with Biogen, to collaborate on CRISPR-based medicines for treating neurological
Continue Reading Scribe Enters CRISPR-Based Collaboration with Biogen
How to protect your mark internationally? Considerations on the Madrid System
Nowadays, the concept of business can rarely prescind from globalization. But the rules and regulations that provide Intellectual Property protection
Continue Reading How to protect your mark internationally? Considerations on the Madrid System